Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Catalent Inc. | 2 | 0 | 0 | 0 | €51.91 | €55.00 | 5.953% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €76.00 | €85.68 | 12.743% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €17.30 | €45.10 | 160.665% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €127.00 | €150.00 | 18.110% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.73 | - | - |
| Repligen Corp. | 12 | 0 | 0 | 0 | €154.50 | €182.96 | 18.421% |
| Davita Inc. | 2 | 0 | 0 | 0 | €123.60 | €124.89 | 1.042% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €294.60 | - | - |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.80 | €65.00 | -2.695% |
| Integer Hldg | 1 | 0 | 0 | 0 | €101.00 | - | - |
| Chemed Corp. | 4 | 0 | 0 | 0 | €530.00 | €588.14 | 10.970% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €336.70 | €369.72 | 9.808% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €87.50 | €124.85 | 42.683% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €10.87 | €22.78 | 109.621% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €60.50 | €75.80 | 25.289% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €213.30 | €247.61 | 16.084% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €74.50 | - | - |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €29.15 | €35.99 | 23.449% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |